<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Pro | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-13T23:44:56+08:00</updated>
  <subtitle>聚焦生物医药前沿，洞察研发投资风向</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>“神刊”CA最新癌症统计：美国癌症死亡率连续第二年破纪录下降</title>
    <updated>2021-01-13T20:58:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/KEeMP4pNpFbrBBroUhKoew</id>
    <link href="https://mp.weixin.qq.com/s/KEeMP4pNpFbrBBroUhKoew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>常兴点评 | Nature里程碑：碱基编辑疗法获突破！治疗早衰症，小鼠寿命从7个月延长至1.5年</title>
    <updated>2021-01-12T20:59:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/T4FxxuaiIIV_D_kdJWyusw</id>
    <link href="https://mp.weixin.qq.com/s/T4FxxuaiIIV_D_kdJWyusw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-1抗体“新搭档”——ENPP1抑制剂</title>
    <updated>2021-01-11T21:02:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/WuwbFh2Eg_dyA7h7vvJwLQ</id>
    <link href="https://mp.weixin.qq.com/s/WuwbFh2Eg_dyA7h7vvJwLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国科学家Science子刊最新成果：抗衰老新靶点—— KAT7</title>
    <updated>2021-01-10T21:00:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/3AGqyQqhUq6mLUbu-D4rzQ</id>
    <link href="https://mp.weixin.qq.com/s/3AGqyQqhUq6mLUbu-D4rzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>主攻CAR-NK！卢冠达创办的公司B轮融资1.05亿美元，开发下一代细胞和基因疗法</title>
    <updated>2021-01-09T20:58:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/YxK0dgULO7rXXqshGwgN3w</id>
    <link href="https://mp.weixin.qq.com/s/YxK0dgULO7rXXqshGwgN3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-M疗法人体试验启动！Carisma宣布完成4700万美元B轮融资，目标是实体瘤</title>
    <updated>2021-01-08T21:00:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/Ng46k3wEfH7-RMh5BFLuHw</id>
    <link href="https://mp.weixin.qq.com/s/Ng46k3wEfH7-RMh5BFLuHw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Cell：一文揭示100多个PROTAC潜在靶点（附详细清单）</title>
    <updated>2021-01-07T21:00:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/Ca8Szz6J5rPda4NK9sW44w</id>
    <link href="https://mp.weixin.qq.com/s/Ca8Szz6J5rPda4NK9sW44w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>主攻NASH新疗法！钟伟东博士创立的拓臻生物C轮融资8700万美元</title>
    <updated>2021-01-06T21:00:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/7AoOYF1URXQzDQoeSGhDOA</id>
    <link href="https://mp.weixin.qq.com/s/7AoOYF1URXQzDQoeSGhDOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>攻向实体瘤！CAR-T疗法新搭档——STING激动剂</title>
    <updated>2021-01-05T21:00:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/PG6RJGcFcefzzabgtRvPAg</id>
    <link href="https://mp.weixin.qq.com/s/PG6RJGcFcefzzabgtRvPAg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【最新综述】胰腺癌免疫疗法的机遇与挑战</title>
    <updated>2021-01-04T21:00:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/lRwIt8nKJfH0n2qXFziBzQ</id>
    <link href="https://mp.weixin.qq.com/s/lRwIt8nKJfH0n2qXFziBzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>